Recombinant human angiotensin-2 converting enzyme (rhACE2) is anticipated as an innovative treatment for severe lung injury and appears to improve pulmonary hemodynamics and oxygen saturation in piglets with lipopolysaccharide-induced acute respiratory distress syndrome .
ACE2 iliyounganishwa ya binadamu (rhACE2) imechukuliwa kuwa matibabu mapya ya majeraha makali ya mapafu, na ilionekana kuboresha mzunguko wa damu mwilini na ukolevu wa oksijeni katika nguruwe wadogo walio na ugonjwa uliosababishwa wa shida kali ya mfumo wa kupumua wa lipopolysaccharide.